Entity Common Stock, Shares Outstanding of Kuvatris Therapeutics, Inc. from Q3 2022 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Kuvatris Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q3 2022 to Q3 2024.
  • Kuvatris Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 20 Sep 2024 was 10,879,170.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Kuvatris Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 10,879,170 20 Sep 2024 10-Q 20 Sep 2024 2024 Q2
Q1 2024 7,408,067 -6,147,325 -45% 11 Mar 2024 10-K 11 Mar 2024 2023 FY
Q4 2023 2,292,715 15 Nov 2023 10-Q 16 Nov 2023 2023 Q3
Q2 2023 16,436,509 09 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 13,555,392 29 Mar 2023 10-K 30 Mar 2023 2022 FY
Q3 2022 11,779,475 30 Sep 2022 10-Q 30 Sep 2022 2022 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.